The Longevity Genes in Founder Populations Project

Summary

We believe extreme longevity is due to specific genes which function to delay aging and prevent disease. The purpose of the research is to identify the genes/mutations associated with healthier aging; to understand the biological functions of these genes/mutations; and to develop therapies to replicate these preservative genetic activities in individuals who do not have the genetic profile for longevity.

Conditions

• Extreme Longevity

Sponsors & Collaborators

• National Institute on Aging (NIA)

  collaborator NIH

• American Federation for Aging Research

  collaborator OTHER

• Weill Medical College of Cornell University

  collaborator OTHER

• Boston University

  collaborator OTHER

• Regeneron Pharmaceuticals

  collaborator INDUSTRY

• Harvard Medical School (HMS and HSDM)

  collaborator OTHER

• Stanford University

  collaborator OTHER

• Tufts Medical Center

  collaborator OTHER

• Columbia University

  collaborator OTHER

• University of Minnesota

  collaborator OTHER

• Rutgers Health

  collaborator UNKNOWN

• University of Rochester

  collaborator OTHER

• Albert Einstein College of Medicine

  lead OTHER

Principal Investigators

• Nir Barzilai, MD · Albert Einstein College of Medicine

Eligibility

Min Age

65 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

1998-07-31

Primary Completion

2032-12-31

Completion

2032-12-31

Countries

• United States

Study Locations